The FDA granted clearance to ArthroCare's SpeedLock HIP Knotless Fixation implant.

Arthrocare's fourth quarter 2012 revenue jumped nearly 4.9 percent from the same period a year ago with total revenue of $96.9 million compared to $92.4 million in 2011.

ArthroCare reported total revenue of $92.4 million during the fourth quarter of 2011, a slight decrease from the $92.6 million reported for the fourth quarter of 2010, according to a company news release.

Sports medicine device company ArthroCare recently reached an agreement in principle to settle pending private securities class action suits against the company and two former officers, according to an ArthroCare news release.

ArthroCare reported $83.3 million in third quarter revenues, a 3.7 percent decrease from the third quarter of 2011, according to an ArthroCare news release.

ArthroCare, a minimally invasive surgical device company, has received FDA clearance for the SpeedLock Knotless Fixation Device, according to a company news release.

Wright Medical Group has entered into a supply and distribution agreement with ArthroCare to distribute devices associated with soft tissue fixation of the foot and ankle, according to a Wright Medical news release.

ArthroCare, a medical device company, sold its Parallax and Contour product lines to NeuroTherm, according to a Zacks report.

David Fitzgerald has been appointed the new president and CEO of ArthroCare Corp., according to a release from ArthroCare.